Men who are initially diagnosed with intermediate-risk prostate cancer may or may not be good candidates for Active Surveillance. This excellent article begins to provide a basis for making that determination. You can read the article by clicking HERE.
Moderately hypofractionated IMRT (radiation therapy delivered in 20 to 26 treatments instead of the conventional 40-44 treatments) has received strong endorsement from all of the major US organizations of physicians who treat prostate cancer. Read more about this significant new guideline here.
So you’ve had your PSA test, and it came back high. Your doctor did a DRE and ran a few more tests, and assures you that prostate cancer is very unlikely. Still, you’re worried. What are some other causes of a high PSA?
Read about this in the Prostate Care Foundation blog HERE
The following presentation slides have some useful information with pros and cons of HDR and LDR Brachytherapy by Daniel Fernandez, MD, PhD. – Moffitt Cancer Center.
View or download the slides from HERE
Reported in Urology Times:
For urologists and radiation oncologists alike, when treating prostate cancer, one recurring theme is “protect the rectum.” As surgeons, we learn meticulous techniques to avoid rectal injuries, and our radiation colleagues have long strategized on how to optimally deliver the maximum dose of tolerable radiation while minimizing radiation exposure to “organs at risk” such as the bladder, rectum, urethra, and penile bulb. In this era of dose escalation and hypofractionation, rectal toxicity is of paramount consideration.
In this article, we discuss one particular new product and how it may herald a significant change in the landscape of radiation therapy for prostate cancer.
Read the entire article on urologytimes.com HERE
The 2018 Genitourinary Cancers Symposium event featured groundbreaking research among members of the cancer care and research community who diagnose, treat, and study genitourinary malignancies.
Click on the below links to view conference proceedings on
Executive director of End Kids Cancer, Frank Kalman, offers advice for facing a cancer diagnosis based on personal experiences.
This is a good article for newbies. Read the article here
Prostate Cancer International announces the development and official opening of its online Active Surveillance Virtual Support Group. This group will meet by webinar or conference call once a month, with the next webinar on Wednesday, December 6, at 2:00 pm Eastern Time (11:00 am Pacific). Registration is required to join.
For more information, click here